Schedule 13G ownership disclosure

CRISPR Therapeutics AG

Security class unavailable · CUSIP: H17182108

Event date: 2019-11-25

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
5,380,940
Percent of class
9.1000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001341004-19-000567
Form type
SC 13G
Filer
CRISPR Therapeutics AG
CIK
CIK 1674416
Filed
Nov 26, 2019
Reporting period
Nov 25, 2019
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub